Form 5500 Search
Back to filter
Original filing (PDF)20251013084517NAL0000389811001

PHATHOM PHARMACEUTICALS, INC.

Form 5500
FILING_RECEIVED
PHATHOM PHARMACEUTICALS, INC. 401(K) PLAN
401(k) retirement plan
Signals · 2
17% employer stockNo recordkeeper disclosed
Active participants
413
Accounts w/ balance
487
Plan assets (EOY)
$27.1M
Net assets (EOY)
$27.1M
How this plan invests
This plan
1 pooled trust
Schedule D
26 securities
funds · stocks · CUSIPs

Holdings are itemized directly on this plan's Schedule of Assets, below.

Plan health score (directional)
96
/ 100
Grade A
Top-tier plan health
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
100
Concentration risk
88
Total plan cost
100
Vendor stack
80
Participation health
100
Knocking points off
  • 17% of plan in employer / sponsor stock.
  • No recordkeeper disclosed on Schedule C.
Helping the score
  • Below-peer total fees (2 bps vs 29 bps peer median).
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for PHATHOM PHARMACEUTICALS, INC..
Plan sponsor
Name
PHATHOM PHARMACEUTICALS, INC.
EIN
82-4151574
Address
100 CAMPUS DRIVE, SUITE 102 · FLORHAM PARK, NJ · 07932
Phone
(908) 967-3324
Industry
Manufacturingsee all
Plan administrator
Same as plan sponsor.
Plan characteristics
Plan number
001
Plan year
2024
Plan year begin
2024-01-01
Tax period
2024-12-31
Filed
2025-10-13
Pension benefit codes
2S · Automatic enrollment
2E · Profit-sharing
3D · Pre-approved plan (master / prototype / VS)
2G · Total participant-directed accounts
2J · 401(k) feature
2K · 401(m) arrangement
2F · ERISA section 404(c)
2T · Default investment account (QDIA)
Audit & trust (Schedule H)
Auditor
LEE CPA AUDIT GROUP
Trustee / custodian
Trustee phone

Service providers (Schedule C)

1 rows
Other
1
NameEINLocationRelationDirect compIndirect comp
THE VANGUARD GROUP, INC.23-1945930NONE$6K

Investments

25 direct securities · 1 pooled fund· $25.0M(92% of reported assets)

Rows tagged as a trust or pooled fund hold many underlying securities. Click one to drill into its own Schedule of Assets — where the individual funds, shares, and CUSIPs live.

Uncategorized
$24.8M
25 holdings
Common Collective Trust
$201K
1 holding
PIInvestmentTypeShares / unitsCostCurrent value% of plan
Phathom Pharm, Inc Common Stock Fund Phathom Pharm 0$4.4M16.1%
Vanguard Target Retirement 2040 Fund Vanguard 0$2.8M10.4%
Vanguard Target Retirement 2030 Fund Vanguard 0$2.8M10.3%
Vanguard Target Retirement 2035 Fund Vanguard 0$2.5M9.3%
Vanguard 500 Index Adm Vanguard 0$2.4M8.7%
Vanguard Target Retirement 2045 Fund Vanguard 0$1.9M7.2%
Vanguard Target Retirement 2050 Fund Vanguard 0$1.5M5.6%
JPMorgan Large Cap Growth R6 JP Morgan 0$1.5M5.5%
Vanguard Target Retirement 2055 Fund Vanguard 0$867K3.2%
BlackRock Mid-Cap Growth Equity K BlackRock 0$776K2.9%
Vanguard Target Retirement 2025 Fund Vanguard 0$611K2.3%
American Eupac R6 American Eupac 0$452K1.7%
Principal SmallCap Growth I R6 Principal 0$337K1.2%
PGIM Total Return Bond R6 PGIM 0$305K1.1%
MFS Value R6 MFS 0$285K1.0%
Vanguard Target Retirement 2060 Fund Vanguard 0$278K1.0%
Vanguard Extended Market Index Adm Vanguard 0$242K0.9%
NY LIFE ANCHOR ACCT SERIES I - 0
NEW YORK LIFE (RELIANCE TRUST) · EIN 46-6350416 / PN 001
Common Collective Trust
$201K0.7%
Various Rates and Maturities Participant's Loan Account 0$188K0.7%
JHancock III Disc Val Mid Cap R6 John Hancock 0$163K0.6%
Vanguard Total Intl Stock Index Adm Vanguard 0$149K0.5%
Vanguard Total Bond Market Index Adm Vanguard 0$123K0.5%
Macquarie Small Cap Value R6 Macquarie 0$122K0.5%
Vanguard Target Retirement Income Fund Vanguard 0$47K0.2%
Vanguard Target Retirement 2065 Fund Vanguard 0$44K0.2%
Vanguard Target Retirement 2070 Fund Vanguard 0$18K<0.1%

Related plans